{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/bb855db2-032d-4062-8c0b-f10155815fa1/690d9824-b02c-4a3c-93b5-c4cd71380595?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"First rounders: Feng Zhang","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/61b9b44742e8562fa5985771/61b9b4a85ca4d10013ea62d9.jpg?height=200","description":"<p>Feng Zhang runs the Zhang Lab at the Massachusetts Institute of Technology. He's also a faculty member at the Broad Institute of MIT and Harvard, and has co-founded several biotech companies, including Editas Medicine. His conversation with Nature Biotechnology covers immigrating to America as a boy, his moment of discovery with CRISPR, and what massive success before the age of 35 does to a researcher.</p>","author_name":"Nature Biotechnology"}